| Product Name | MF | CAS | Details |
|---|
| 4-Methoxystilbene | C15H14O | 1142-15-0 | Details |
| N-(7-(azamethoxyethylene)-5,5-dimethyl-4,5,6-trihydrobenzothiazol-2-yl)ethanamide | C13H19N3O2S | 1159976-67-6 | Details |
| 4-(3-Bromopropyl)-1H-pyrazole | C6H9BrN2 | 82100-00-3 | Details |
| Benzeneacetic acid, 4-bromo-3-methoxy- | C9H9BrO3 | 99548-57-9 | Details |
| Despropylrotigotine | C16H19NOS | 153409-14-4 | Details |
| GPi 688 | C19H18ClN3O4S | 918902-32-6 | Details |
| Bicalutamide | C18H14F4N2O4S | 90357-06-5 | Details |
| (6-Methyl-1-benzothiophen-2-yl)boronic acid | C9H9BO2S | 820240-91-3 | Details |
| (1R,2R)-1,2-Cyclohexanedimethanol | C8H16O2 | 65376-05-8 | Details |
| Methyl 3-[5-cyclopropyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]propanoate | C11H13F3N2O2 | 1002033-74-0 | Details |
| P38Α inhibitor 1 | C22H26F2N4O2 | 1034189-82-6 | Details |
| H-EDSQCVIGLYQPPLQVY-OH | Details |
| 2-Bromo-N-tert-butyl-3-methylbutanamide | C9H18BrNO | 95904-26-0 | Details |
| 2-Methyl-N-(4-piperidin-1-ylsulfonylphenyl)-5-(trifluoromethyl)pyrazole-3-carboxamide | C17H19F3N4O3S | 949898-66-2 | Details |
| Ac-Ala-Ala-Ala-pNA | C17H23N5O6 | 40817-33-2 | Details |
| FLT3LG antibody | Details |
| 2-(2,6-Dioxopiperidin-3-yl)-4-(prop-2-yn-1-ylamino)isoindoline-1,3-dione | C16H13N3O4 | 2154342-25-1 | Details |
| Lodelcizumab | 1355338-54-3 | Details |
| Gamithromycin | C40H76N2O12 | 145435-72-9 | Details |
| Methyl 5-amino-2-bromoisonicotinate | C7H7BrN2O2 | 1363383-38-3 | Details |
| methyl 4-bromo-6-chloropyridine-2-carboxylate | C7H5BrClNO2 | 1206249-86-6 | Details |
| RCE1 antibody | Details |
| XRCC3 protein (His tag) | Details |
| N-Benzyl-4-chloropyrimidin-2-amine | C11H10ClN3 | 71406-63-8 | Details |
| (5-bromo-1h-indol-3-yl)methanol | C9H8BrNO | 92557-51-2 | Details |
| 2-Chloro-5-(piperidin-4-ylmethoxy)pyridine | C11H15ClN2O | 1515960-91-4 | Details |
| tert-Butyl 4-formyl-1H-pyrazole-1-carboxylate | C9H12N2O3 | 821767-61-7 | Details |
| Mecetronium ethylsulfate | C22H49NO4S | 3006-10-8 | Details |
| D-Galactose-1-phosphate disodium | C6H14NaO9P | 147072-63-7 | Details |
| 1-(2,2-Difluorocyclopropyl)-1H-pyrazole | C6H6F2N2 | 2155856-09-8 | Details |
| Heptanoyl chloride | C7H13ClO | 2528-61-2 | Details |
| N3-PEG5-CH2CH2NH2 | C12H26N4O5 | 516493-93-9 | Details |
| Jervine | C27H39NO3 | 469-59-0 | Details |
| C.I.Disperse Red 362 | 158129-94-3 | Details |
| NEU4 Blocking Peptide | Details |
| SCP2D1 protein (His tag) | Details |
| Methyl 2-chloro-3-methylbenzoate | C9H9ClO2 | 920759-93-9 | Details |
| Rivastigmine hydrochloride | C14H22N2O2.ClH | 727418-36-2 | Details |
| 1-(2-(Bromomethyl)phenyl)propan-2-one | C10H11BrO | 1334292-32-8 | Details |
| Foscarnet impurity B | C3H8NaO5P | 55920-24-6 | Details |
| Amonafide-d6 | C16H17N3O2 | 1217039-92-3 | Details |
| 3-Bromo-1-(4-fluorophenyl)-1H-1,2,4-triazole | C8H5BrFN3 | 623577-63-9 | Details |
| OTS514 hydrochloride | C21H21ClN2O2S | 2319647-76-0 | Details |
| rac-Methyl (2R,5S)-5-[4-(trifluoromethyl)phenyl]oxolane-2-carboxylate | C13H13F3O3 | 2044705-95-3 | Details |
| 2,3-Dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-1H-indole-7-carbonitrile | C25H30F3N3O3 | 885340-13-6 | Details |
| 2,2,2-Trifluoro-1-[2-(trifluoromethyl)phenyl]ethan-1-amine hydrochloride | C9H8ClF6N | 1443981-34-7 | Details |
| Roscovitine | C19H26N6O | 186692-46-6 | Details |
| 2-(Piperidin-3-yl)-acetic acid ethyl ester | C9H17NO2 | 64995-88-6 | Details |
| 3-(3-Fluorooxetan-3-yl)benzoic acid | C10H9FO3 | 1443759-41-8 | Details |
| 2-(3-Hydroxy-2-(3-hydroxypicolinamido)phenyl)benzo[D]oxazole-4-carboxylic acid | C20H13N3O6 | 80148-45-4 | Details |
| Ethyl 5-formyl-1-methyl-1H-pyrazole-4-carboxylate | C8H10N2O3 | 40995-41-3 | Details |
| H-LTIGEGQQHHLGGAKQAGDV-OH | Details |
| 4-Chloro-N-(3-chloro-1-phenylpropyl)benzene-1-sulfonamide | C15H15Cl2NO2S | 857041-71-5 | Details |
| 5-Chloro-3,4-dihydro-2H-1-benzopyran-3-one | C9H7ClO2 | 1154740-80-3 | Details |
| 5-(2H-1,2,3,4-Tetrazol-5-yl)pyridin-2-amine | C6H6N6 | 13566-35-3 | Details |
| 2-Methylphenoxyacetic acid | C9H10O3 | 1878-49-5 | Details |
| Ethynyl estradiol 17-b-D-glucuronide | C26H32O8 | 75803-39-3 | Details |
| Diphenyl(4-phenylthio)phenylsufonium hexafluorophosphate | C24H19F6PS2 | 68156-13-8 | Details |
| Ethyl 2-cyclobutylprop-2-enoate | C9H14O2 | 2116815-68-8 | Details |
| tert-Butyl 3-(methylamino)-1,1-dioxo-1λ6-thia-7-azaspiro[3.5]nonane-7-carboxylate | C13H24N2O4S | 2228090-75-1 | Details |
| 3-Methylazetidine-3-carboxamide hydrochloride | C5H11ClN2O | 1909328-11-5 | Details |
| Cystatin B antibody | Details |
| Ethyl 5-[(4-methylphenyl)amino]-1,3-thiazole-4-carboxylate | C13H14N2O2S | 1408107-25-4 | Details |
| BEST3 Blocking Peptide | Details |
| 3-Methyl-2-hexanone | C7H14O | 2550-21-2 | Details |
| {2-[4-(4-Methanesulfonylphenyl)-1H-imidazol-2-yl]ethyl}(propan-2-yl)amine | C15H21N3O2S | 1184436-23-4 | Details |
| 2-(1-Benzylpiperidin-4-ylidene)-2-phenylacetonitrile | C20H20N2 | 6517-69-7 | Details |
| Dichloro[(S,S)-ethylenebis(4,5,6,7-tetrahydro-1-indenyl)]titanium(IV) | C20H24Cl2Ti | 83462-46-8 | Details |
| rac-tert-Butyl N-[(1R,3S)-3-(sulfamoylmethyl)cyclopentyl]carbamate | C11H22N2O4S | 2138422-71-4 | Details |
| 1-(3-Bromobenzoyl)-2-(2-naphthoyl)-hydrazine | C18H13BrN2O2 | 84282-41-7 | Details |
| 2,2,6,6-Tetramethylpiperidinyl zinc chloride lithium chloride complex solution - 1M THF | C9H18Cl2LiNZn | 1145881-09-9 | Details |
| [1',2',3',4',5'-13C5]-4-Thiothymidine | Details |
| H-MSLLTEVETPIRNEWGCRCNDSSD-NH2 | Details |
| 5-Ethoxyspiro[2.3]hexan-1-amine hydrochloride | C8H16ClNO | 2094312-44-2 | Details |
| 2-[(5-Chloro-2,4-dimethoxyphenyl)(2-hydroxyethyl)amino]ethan-1-ol | C12H18ClNO4 | 1311315-03-3 | Details |
| 6-Methoxy-3-phenyl-1-benzofuran-2-carboxylic acid | C16H12O4 | 58468-43-2 | Details |
| methyl 7-(3-methoxypropyl)-1,3-dimethyl-2,4-dioxo-2,3,4,7-tetrahydro-1h-pyrrolo[2,3-d]pyrimidine-6-carboxylate | C14H19N3O5 | 1086386-38-0 | Details |
| Suc-KRRKQ-NH2 | Details |
| N,5-Dimethyl-1,3-thiazolidin-2-imine | C5H10N2S | 21018-31-5 | Details |
| N-(5-Bromoacetamidylpentyl) acrylamide | C10H17BrN2O2 | 859161-71-0 | Details |
| 3-prop-2-ynyl-2-thioxo-1,3-dihydroquinazolin-4-one | C11H8N2OS | 497060-22-7 | Details |
| Sar-[D-Phe8]-des-Arg9-bradykinin | C47H66N12O11 | 126959-88-4 | Details |
| R(+)-Baclofen.Hydrochloride | C10H13Cl2NO2 | 63701-55-3 | Details |
| 1-Benzyl-2,3-dihydro-1H-indol-5-amine hydrochloride | C15H17ClN2 | 1210277-79-4 | Details |
| Benzooxazole-2-carboxylic acid amide | C8H6N2O2 | 3313-38-0 | Details |
| 4-bromo-3-((2-chlorophenoxy)methyl)-2-methyl-1-phenyl-3-pyrazolin-5-one | C17H14BrClN2O2 | 946386-46-5 | Details |
| 1,4-Phenylenediacrylic acid diethyl ester | C16H18O4 | 17088-28-7 | Details |
| 2-(Bromomethyl)adamantane | C11H17Br | 42067-69-6 | Details |
| AZD 4407 | C19H21NO3S2 | 166882-70-8 | Details |
| 2,3-Dihydro-1H-pyrrolizine-6-carboxylic acid | C8H9NO2 | 1509635-59-9 | Details |
| BMP2K antibody | Details |
| 5-O-tert-Butyldimethylsilyl-2,3-O-isopropylidene-L-lyxofuranose | C14H26O5Si | 1266546-81-9 | Details |
| IgG1 Lambda Myeloma Human Plasma | Details |
| Histone Antibody Positive Human Plasma | Details |
| IGLL1 antibody | Details |
| 8-(tert-Butoxycarbonyl)-1-oxa-8-azaspiro[4.5]decane-2-carboxylic acid | C14H23NO5 | 1160246-88-7 | Details |
| CD103 antibody (Azide Free) | Details |
| Scyliorhinin I, Scy I | C59H87N13O13S | 103425-21-4 | Details |
| 1-(Azetidin-3-yl)-4-(3-methyl-1,2,4-oxadiazol-5-yl)pyrrolidin-2-one hydrochloride | 2126161-76-8 | Details |
| Indicaxanthin | C14H16N2O6 | 2181-75-1 | Details |
| Product Total： Product Page： | ||||
| 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 | ||||